Evidence map›Paper›PMID 20659159›Full record

ReviewThe FEBS journal2010

The molecular identity of the mitochondrial Ca2+ sequestration system.

Anatoly A Starkov

Open access · bronzeAbstract readReview
In one paragraph

Review in The FEBS journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Differential CaFrontiers in synaptic neuroscience · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The Emerging Role ofFrontiers in neurology · 2020
    Review
  8. Total Matrix CaFrontiers in physiology · 2020
    Article
  9. Article
  10. Emerging molecular therapeutic targets for spinal cord injury.Expert opinion on therapeutic targets · 2019
    Review
  11. Article
  12. Arginase II Contributes to the CaJournal of the American Heart Association · 2018
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Anatoly A StarkovWeill Medical College of Cornell University, New York, NY, USA. ans2024@med.cornell.edu
Cornell University · US

Funding

Molecular mechanisms of Ca2+ retention in mitochondriaR21NS065396 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI STARKOV, ANATOLY A · 2009 to 2010
$422k
NINDS NIH HHS NS065396NINDS NIH HHS R21 NS065396
6 · The paper itself

Abstract

There is ample evidence to suggest that a dramatic decrease in mitochondrial Ca(2+) retention may contribute to the cell death associated with stroke, excitotoxicity, ischemia and reperfusion, and neurodegenerative diseases. Mitochondria from all studied tissues can accumulate and store Ca(2+) , but the maximum Ca(2+) storage capacity varies widely and exhibits striking tissue specificity. There is currently no explanation for this fact. Precipitation of Ca(2+) and phosphate in the mitochondrial matrix has been suggested to be the major form of storage of accumulated Ca(2+) in mitochondria. How this precipitate is formed is not known. The molecular identity of almost all proteins involved in Ca(2+) transport, storage and formation of the permeability transition pore is also unknown. This review summarizes studies aimed at identifying these proteins, and describes the properties of a known mitochondrial protein that may be involved in Ca(2+) transport and the structure of the permeability transition pore.

Indexed as

AnimalsCalciumCalcium PhosphatesCalcium SignalingHumansMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial ProteinsModels, BiologicalOrgan SpecificityCalciumCalcium PhosphatesMitochondrial Membrane Transport ProteinsMitochondrial Proteins

Identifiers

PMID20659159
PMCPMC3725145
OpenAlexW1564026327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.